BetterLife Pharma (BETRF) Assets Average (2011 - 2026)
BetterLife Pharma (BETRF) posted quarterly Assets Average of $167654.1 for Q2 2026, up 4.33% year-over-year from $160702.3 in Q2 2025, and up 3.06% quarter-over-quarter from $162682.9 in Q1 2026.
BetterLife Pharma (BETRF) Assets Average (2011 - 2026) Analysis & Trends
BetterLife Pharma's Assets Average history runs 16 years deep, the most recent figure standing at $167654.1 for Q2 2026.
- In Q2 2026, Assets Average rose 4.33% year-over-year to $167654.1; the TTM figure through Apr 2026 stood at $167654.1 (up 4.33% YoY), while the FY2026 annual figure was $158462.7, down 20.51% from the prior year.
- Assets Average for Q2 2026 stood at $167654.1, up from $162682.9 in the prior quarter.
- The five-year high for Assets Average was $1.7 million in Q1 2022, with the low at $132801.9 in Q1 2023.
- The 5-year median for Assets Average is $263573.1 (2024), against an average of $362494.2.
- The sharpest annual moves came in 2022 and 2024: Assets Average plunged 94.24% in 2022, then soared 131.92% in 2024.
- BetterLife Pharma's Assets Average stood at $202537.8 in 2022, then surged by 66.67% to $337571.5 in 2023, then fell by 21.92% to $263573.1 in 2024, then sank by 37.43% to $164922.5 in 2025, then advanced by 1.66% to $167654.1 in 2026.
- Business Quant data shows BETRF's Assets Average at $167654.1 in Q2 2026, $162682.9 in Q1 2026, and $164922.5 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.34 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.09 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.27 Bn |
| 10 | BetterLife Pharma | 40.15 Mn | 42.53 Mn | - | 167,654.06 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 167,654.06 |
| Jan 31, 2026 | 162,682.86 |
| Jul 31, 2025 | 164,922.48 |
| Apr 30, 2025 | 160,702.33 |
| Jan 31, 2025 | 178,597.78 |
| Oct 31, 2024 | 263,573.07 |
| Jul 31, 2024 | 456,467.07 |
| Apr 30, 2024 | 412,367.59 |
| Jan 31, 2024 | 307,995.11 |
| Oct 31, 2023 | 337,571.49 |
| Jul 31, 2023 | 416,604.76 |
| Apr 30, 2023 | 294,618.68 |
| Jan 31, 2023 | 132,801.90 |
| Oct 31, 2022 | 202,537.79 |
| Jul 31, 2022 | 239,320.83 |
| Apr 30, 2022 | 600,669.64 |
| Jan 31, 2022 | 1.66 Mn |
| Oct 31, 2021 | 3.52 Mn |
| Jul 31, 2021 | 2.88 Mn |
| Apr 30, 2021 | 1.10 Mn |